BSG and hepatocellular carcinoma: Our findings potentially shed light on the molecular regulation of CD147 by glycosylation and provide a valuable (glyco) biomarker for developing drugs that target N-glycosylation at Asn152 on CD147, which may represent aneffective strategy for the early diagnosis, risk stratification, and development of therapeutic strategies for treating HCC in the clinical setting.